The global peptide drug conjugates market is gaining significant momentum as pharmaceutical and biotechnology companies increasingly focus on targeted drug delivery and precision medicine. Peptide drug conjugates (PDCs) combine the targeting capabilities of peptides with therapeutic payloads, enabling more selective delivery to specific cells or tissues. Their potential to improve treatment...